Trade FLNA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Filana Therapeutics, Inc. (FLNA) is trading at US$0.70, down 7.53% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$46.42M. Over the past 52 weeks, FLNA has traded between US$0.67 and US$4.69. On Syfe you can trade FLNA with $0 commission and add it to your watchlist.
| Previous close | US$0.76 |
|---|---|
| Market cap | US$46.42M |
| 52-week range | US$0.67 – US$4.69 |
| Volume | 327.63K |
| Exchange | US |
Filana Therapeutics, Inc.
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Year: 2000
Filana Therapeutics, Inc. (FLNA) stock is trading at US$0.70, -7.53% from the previous close of US$0.76.
The market cap for Filana Therapeutics, Inc. (FLNA) stock is approximately US$46.42M.
The 52-week high for Filana Therapeutics, Inc. (FLNA) stock is US$4.69.
The 52-week low for Filana Therapeutics, Inc. (FLNA) stock is US$0.67.
Filana Therapeutics, Inc. (FLNA) does not currently pay a dividend.
Stay on top of FLNA
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
